Concepedia

Author

Philip D. Yin

Bristol-Myers Squibb (United States)

Also Known As

Philip D Yin, Philip D. Yin, Philip Yin

33

Publications

1.4K

Citations

17

H-Index

16

Concepts

All Affiliations

Bristol-Myers Squibb (United States)InsermJohns Hopkins UniversityAssistance Publique – Hôpitaux de ParisTexas Liver Institute
PD

About

Philip D. Yin is an author at Bristol-Myers Squibb (United States) specializing in medicine, viral hepatitis, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

308

2

Cell Biology

1

1

60

3

Epidemiology

1

1

45

4

Hepatology

1

1

147

5

Immunology

1

1

60

Philip D. Yin

×

17

Publications

1.4K

Citations

17

H-Index

YearCitations

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

David Wyles, Peter Ruane, Mark Sulkowski,

New England Journal of Medicine

2015

418

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

Stanislas Pol, Reem Ghalib, Vinod K. Rustgi,

The Lancet Infectious Diseases

2012

147

Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis

Andrew J. Muir, Fred Poordad, Jacob Lalezari,

JAMA

2015

126

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

Christophe Hézode, Gideon M. Hirschfield, Wayne Ghesquière,

Gut

2014

118

Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

Fred Poordad, William Sievert, Lindsay Mollison,

JAMA

2015

94

Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C

Tariq Ahmad, Philip D. Yin, Jeffrey E. Saffitz,

Hepatology

2014

84

Correlated Template-Switching Events during Minus-Strand DNA Synthesis: a Mechanism for High Negative Interference during Retroviral Recombination

Jeffrey A. Anderson, Ronald J. Teufel, Philip D. Yin,

Journal of Virology

1998

61

Involvement of the Second Extracellular Loop and Transmembrane Residues of CCR5 in Inhibitor Binding and HIV-1 Fusion: Insights into the Mechanism of Allosteric Inhibition

Kenji Maeda, Debananda Das, Philip D. Yin,

Journal of Molecular Biology

2008

60

Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: Successful management with intravitreal injections and monitoring with quantitative PCR

Philip D. Yin, Shree K. Kurup, Steven H. Fischer,

Journal of Clinical Virology

2007

56

Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection

Joji Toyota, Yoshiyasu Karino, Fumitaka Suzuki,

Journal of Gastroenterology

2016

45

Page 1